Terry-Ann Burrell's Net Worth

$16.6 Million

Estimate Recalculated Apr 2, 2025 08:06PM EST

Who is Terry-Ann Burrell

Terry-Ann Burrell has an estimated net worth of $16.6 Million. This is based on reported shares across multiple companies, which include Beam Therapeutics Inc., RECURSION PHARMACEUTICALS, INC., and Rapport Therapeutics, Inc..

SEC CIK

Terry-Ann Burrell's CIK is 0001786484

Past Insider Trading and Trends

2021 was Terry-Ann Burrell's most active year for acquiring shares with 13 total transactions. Terry-Ann Burrell's most active month to acquire stocks was the month of December. 2021 was Terry-Ann Burrell's most active year for disposing of shares, totalling 23 transactions. Terry-Ann Burrell's most active month to dispose stocks was the month of December. 2024 saw Terry-Ann Burrell paying a total of $1,342,000.00 for 162,600 shares, this is the most they've acquired in one year. In 2021 Terry-Ann Burrell cashed out on 749,999 shares for a total of $10,550,501.25, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Beam Therapeutics Inc.

Chief Financial Officer
Updated Apr 29, 2024
Form 4
53.47%
37.50K
Apr 29, 2024
107.64K
Grant
Apr 26
Form 4
-7.21%
-5.45K
$32.12
-$174.93K
Apr 03, 2024
70.14K
Sale
Apr 01
Form 4
57.19%
27.50K
Apr 02, 2024
75.58K
Grant
Mar 31
Form 4
55.00K
$24.40
$1.34M
Feb 02, 2024
55.00K
Grant
Jan 31
Form 4/A
40.00K
Apr 19, 2023
40.00K
Grant
Jan 31
Form 4
-8.96%
-4.64K
$29.74
-$137.98K
Apr 05, 2023
47.12K
Sale
Apr 03 - Apr 04
Form 4
127.89%
40.00K
Mar 31, 2023
71.28K
Grant
Jan 31 - Mar 31
Form 4
-14.66%
-37.25K
$29.38
-$1.17M
Jan 30, 2023
216.84K
Sale
ScheduledJan 26 - Jan 27
Form 4
-7.38%
-20.24K
$29.35
-$634.12K
Jan 25, 2023
254.10K
Sale
ScheduledJan 23 - Jan 24
Form 4
-14.68%
-47.20K
$29.41
-$1.58M
Jan 20, 2023
274.33K
Sale
ScheduledJan 18
Form 4
52.71%
13.21K
$59.11
-$105.63K
Apr 04, 2022
38.28K
Grant
Mar 31
Form 4
30.00K
Feb 02, 2022
30.00K
Grant
Jan 31
Form 4
-8.88%
-30.00K
$67.84
-$3.25M
Jul 02, 2021
307.75K
Sale
ScheduledJun 30
Form 4
-11.76%
-45.00K
$60.69
-$4.23M
Jun 30, 2021
337.75K
Sale
ScheduledJun 28
Form 4
718.29%
52.50K
Apr 02, 2021
59.81K
Grant
Mar 31
Form 4
-6.41%
-25.00K
$47.73
-$1.70M
Jan 05, 2021
365.25K
Sale
ScheduledJan 04
Form 4
$13.68
$99.99K
Sep 21, 2020
390.25K
Options
Sep 18
Form 3
Feb 05, 2020
Showing 18 results

RECURSION PHARMACEUTICALS, INC.

Investor
Updated Jul 03, 2024
Form 4
2.66%
1.84K
Jul 03, 2024
71.25K
Grant
Jul 01
Form 4
69.77%
39.29K
Jun 05, 2024
95.60K
Grant
Jun 03
Form 4
2.67%
1.47K
Apr 03, 2024
56.31K
Grant
Apr 01
Form 4
-68.08%
-117.00K
$12.07
-$1.41M
Jul 14, 2023
54.85K
Sale
Jul 12 - Jul 13
Form 4
23.76%
37.84K
Jun 21, 2023
650.55K
Grant
Jun 16
Form 4
1.16%
1.82K
Jan 05, 2023
159.24K
Grant
Jan 03
Form 4
0.81%
1.26K
Oct 05, 2022
157.41K
Grant
Oct 03
Form 4
1.06%
1.63K
Jul 06, 2022
156.15K
Grant
Jul 01
Form 4
39.92%
54.44K
Jun 16, 2022
608.00K
Grant
Jun 14
Form 4
1.33%
1.79K
Apr 05, 2022
136.37K
Grant
Apr 01
Form 4
0.57%
763.00
Jan 05, 2022
134.59K
Grant
Jan 03
Form 4
0.47%
629.00
Oct 05, 2021
133.82K
Grant
Oct 01
Form 4
0.29%
382.00
Jul 06, 2021
133.19K
Grant
Jul 01
Form 4
Apr 22, 2021
550.00K
Options
Apr 20
Form 4
15.58%
18.75K
Apr 19, 2021
543.75K
Grant
Apr 15 - Apr 16
Form 3
Apr 15, 2021
120.31K
Showing 16 results

Rapport Therapeutics, Inc.

Investor
Updated Jun 06, 2024
Form 3
Jun 06, 2024
Showing 1 results